Endre Kolossváry

669 total citations
29 papers, 330 citations indexed

About

Endre Kolossváry is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Endre Kolossváry has authored 29 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Endre Kolossváry's work include Peripheral Artery Disease Management (23 papers), Diabetic Foot Ulcer Assessment and Management (10 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Endre Kolossváry is often cited by papers focused on Peripheral Artery Disease Management (23 papers), Diabetic Foot Ulcer Assessment and Management (10 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Endre Kolossváry collaborates with scholars based in Hungary, United Kingdom and Argentina. Endre Kolossváry's co-authors include Katalin Farkas, Zoltán Járai, János Nemcsik, Csaba Farsang, István Kiss, Tamás Ferenci, Michael Edmonds, M. Catalano, Martin Björck and Denis Clément and has published in prestigious journals such as Atherosclerosis, Nephrology Dialysis Transplantation and Journal of Hypertension.

In The Last Decade

Endre Kolossváry

27 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Endre Kolossváry Hungary 10 140 102 95 84 56 29 330
Hélène Safar France 10 76 0.5× 293 2.9× 66 0.7× 53 0.6× 80 1.4× 14 456
T. Trinick United Kingdom 12 86 0.6× 129 1.3× 65 0.7× 76 0.9× 51 0.9× 17 449
Sundararajan Srikanth United States 10 95 0.7× 166 1.6× 40 0.4× 69 0.8× 62 1.1× 15 376
Luca Monzo France 10 81 0.6× 334 3.3× 152 1.6× 91 1.1× 56 1.0× 69 545
Aferdita Spahillari United States 10 56 0.4× 145 1.4× 61 0.6× 32 0.4× 18 0.3× 20 348
Matteo Serenelli Italy 13 139 1.0× 457 4.5× 109 1.1× 154 1.8× 99 1.8× 41 706
Hanna Fröhlich Germany 15 92 0.7× 263 2.6× 26 0.3× 98 1.2× 64 1.1× 33 436
E. T. Lee United States 11 153 1.1× 120 1.2× 66 0.7× 368 4.4× 46 0.8× 14 663
Suzanne Goldberg United States 6 245 1.8× 133 1.3× 14 0.1× 57 0.7× 91 1.6× 9 342
Kathleen Rich United States 7 259 1.9× 48 0.5× 18 0.2× 64 0.8× 92 1.6× 24 368

Countries citing papers authored by Endre Kolossváry

Since Specialization
Citations

This map shows the geographic impact of Endre Kolossváry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Endre Kolossváry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Endre Kolossváry more than expected).

Fields of papers citing papers by Endre Kolossváry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Endre Kolossváry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Endre Kolossváry. The network helps show where Endre Kolossváry may publish in the future.

Co-authorship network of co-authors of Endre Kolossváry

This figure shows the co-authorship network connecting the top 25 collaborators of Endre Kolossváry. A scholar is included among the top collaborators of Endre Kolossváry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Endre Kolossváry. Endre Kolossváry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolossváry, Endre, et al.. (2026). Alternative ankle–brachial assessments show no significant added value in predicting mortality of hypertensive patients. Journal of Hypertension. 44(4). 682–690.
2.
Kolossváry, Endre, Katalin Farkas, Oğuz Karahan, et al.. (2023). The importance of socio-economic determinants of health in the care of patients with peripheral artery disease: A narrative review from VAS. Vascular Medicine. 28(3). 241–253. 15 indexed citations
3.
Farkas, Katalin, et al.. (2022). Ankle Brachial Index is a strong predictor of mortality in hypertensive patients: results of a five-year follow-up study. International Angiology. 41(6). 517–524. 2 indexed citations
4.
Kolossváry, Endre, Ildikò Szabó, Edit Dósa, et al.. (2022). Az alsó végtagi endovascularis verőér-beavatkozások során alkalmazott antithromboticus, antikoaguláns terápia szempontjai. Orvosi Hetilap. 163(3). 98–108. 1 indexed citations
6.
Farkas, Katalin, Endre Kolossváry, & Zoltán Járai. (2020). A cilostazol diabeteses betegekben is javítja az életminőséget és az alsó végtagi funkcionális kapacitást. Orvosi Hetilap. 161(38). 1637–1645. 4 indexed citations
7.
Kolossváry, Endre, Tamás Ferenci, Levente Kovács, et al.. (2019). Lower Limb Amputations and Revascularisation Procedures in the Hungarian Population: A 14 Year Retrospective Cohort Study. European Journal of Vascular and Endovascular Surgery. 59(3). 447–456. 14 indexed citations
8.
9.
Járai, Zoltán, et al.. (2018). A boka-kar index oszcillometriás elven működő meghatározásának helye a klinikai gyakorlatban = The potential role of oscillometric devices for ankle-brachial index measurements in clinical practice. 1 indexed citations
10.
Farkas, Katalin, Endre Kolossváry, Zoltán Járai, András Paksy, & Imre Kiss. (2018). MORTALITY RATES IN HYPERTENSIVE SUBJECTS WITH PERIPHERAL ARTERIAL DISEASE. Journal of Hypertension. 36(Supplement 1). e1–e2.
11.
Kolossváry, Endre, Katalin Farkas, Mary Paula Colgan, et al.. (2017). "No more amputations": a complex scientific problem and a challenge for effective preventive strategy implementation on vascular field. International Angiology. 36(2). 107–115. 16 indexed citations
12.
Farkas, Katalin, Zoltán Járai, & Endre Kolossváry. (2017). A cilostazol hatékony és biztonságos lehetőség a claudicatio intermittens kezelésére. A NOCLAUD vizsgálat eredményei | Cilostazol is effective and safe option for the treatment of intermittent claudicationResults of the NOCLAUD study. 2 indexed citations
13.
Kolossváry, Endre, et al.. (2017). A diabeteses láb ischaemiás eredete. Epidemiológia, a diagnózis nehézségei, prevenciós és revascularisatiós lehetőségek. Orvosi Hetilap. 158(6). 203–211. 10 indexed citations
14.
Farkas, Katalin, Zoltán Járai, & Endre Kolossváry. (2017). A cilostazol hatékony és biztonságos lehetőség a claudicatio intermittens kezelésére. A NOCLAUD vizsgálat eredményei. Orvosi Hetilap. 158(4). 123–128. 4 indexed citations
15.
Kolossváry, Endre, et al.. (2015). Trends in Major Lower Limb Amputation Related to Peripheral Arterial Disease in Hungary: A Nationwide Study (2004–2012). European Journal of Vascular and Endovascular Surgery. 50(1). 78–85. 34 indexed citations
16.
Farkas, Katalin, et al.. (2012). High prevalence of peripheral arterial disease in hypertensive patients. Journal of Hypertension. 30(8). 1526–1532. 20 indexed citations
17.
Nemcsik, János, Katalin Farkas, Endre Kolossváry, et al.. (2007). Intracardiac Calcification Is a Marker of Generalized Atherosclerosis. Angiology. 58(4). 413–419. 10 indexed citations
18.
Farkas, Katalin, János Nemcsik, Endre Kolossváry, et al.. (2005). Impairment of skin microvascular reactivity in hypertension and uraemia. Nephrology Dialysis Transplantation. 20(9). 1821–1827. 40 indexed citations
19.
Farkas, Katalin, Endre Kolossváry, Zoltán Járai, János Nemcsik, & Csaba Farsang. (2004). Non-invasive assessment of microvascular endothelial function by laser doppler flowmetry in patients with essential hypertension. Atherosclerosis. 173(1). 97–102. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026